Skip to main content
. 2022 Dec 6;14(12):e32247. doi: 10.7759/cureus.32247

Figure 2. Schematic overview of starting treatment, discontinuing treatment, and typical course observed after treatment discontinuation.

Figure 2

HBV DNA: Hepatitis B virus deoxyribonucleic acid, ALT: Alanine aminotransferase, ULN: Upper limit of normal, HBsAg: Hepatitis B surface antigen, HBeAg: Hepatitis B e antigen, NA: Nucleoside analog, LLOQ: Low limit of quantity